Rare-disease drug developer (hereditary angioedema)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 53 | New buy | 848,336 | $8,483,360 | 0.1% |
| Steve Cohen / Point72 | 76 | New buy | 260,917 | $2,609,170 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Added +198% | 285,028 | $2,850,280 | 0.0% |
| Bridgewater | 56 | Trimmed -23% | 491,057 | $4,910,570 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-07-10 | Gilbert Cisneros CA31 | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.